Search results
Results from the WOW.Com Content Network
There is a purported correlation (but no proven causal link) between the use of PPIs and the risk of dementia. [6] However, this remain controversial as chronic and co-morbid pathology, and resultant polypharmacy (including increased consumption of PPIs), will probably itself also give rise to an increased risk of dementia as a whole.
A new study found a link between certain types of acid reflux medications and dementia. The study analyzed data from more than 5,000 people.
Popular Heartburn Drugs Linked to Dementia Risk, Study Shows (Reuters Health) -- Repeated use of a certain class of drugs for gastric reflux or peptic ulcers was linked with a higher risk for ...
A recent 2024 study published in the Journal of Clinical Endocrinology & Metabolism found that chronic use of PPIs in men is linked to lower trabecular bone quality. [40] Specifically, PPI use was associated with reduced lumbar spine trabecular bone score (TBS), as well as lower bone mineral density (BMD) T-scores in the lumbar spine, total hip ...
Scientists did not find higher risk of dementia among people who took the drugs for fewer than 4.4 years. Skip to main content. 24/7 Help. For premium support please call: 800-290 ...
Pantoprazole, sold under the brand name Protonix, among others, is a medication used for the treatment of stomach ulcers, short-term treatment of erosive esophagitis due to gastroesophageal reflux disease (GERD), maintenance of healing of erosive esophagitis, and pathological hypersecretory conditions including Zollinger–Ellison syndrome.
Pantoprazole was first prepared in April 1985 by a small group of scale-up chemists. It is a dimethoxy-substituted pyridine bound to a fluoroalkoxy substituted benzimidazole. [5] Pantoprazole sodium is available as gastroresistant or delayed release tablets and as lyophilized powder for intravenous use.
Researchers are currently experimenting with drugs which induce amnesia in order to improve understanding of human memory, and develop better drugs to treat psychiatric disorders and memory-related disorders. People with Alzheimer's disease and other forms of dementia are likely to benefit.